Intrafractional motion detection for spine SBRT via X-ray imaging using ExacTrac Dynamic (2024) Muecke J, Reitz D, Huang L, da Silva Mendes V, Landry G, Reiner M, Belka C, et al. Journal article Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12) (2024) Bodensohn R, Fleischmann DF, Maier SH, Anagnostatou V, Garny S, Nitschmann A, Büttner M, et al. Journal article The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours (2024) Hering S, Nieto A, Marschner S, Hofmaier J, Schmidt-Hegemann NS, da Silva Mendes V, Landry G, et al. Journal article Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data (2024) Shouman MA, Fuchs F, Walter F, Corradini S, Westphalen CB, Vornhülz M, Beyer G, et al. Journal article Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey (2023) Boldrini L, Alongi F, Romano A, Charles Davies D, Bassetti M, Chiloiro G, Corradini S, et al. Journal article Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis (2023) Annede P, Ferre M, Kirisits C, Pieters BR, Schmid M, Strnad V, Westerveld H, Chargari C Journal article Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al. Journal article PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma (2022) Göbel HH, Distel L, Aigner T, Büttner-Herold M, Grabenbauer GG Journal article Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial (2021) Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V Journal article Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma (2021) Meneghetti AR, Zwanenburg A, Leger S, Leger K, Troost EGC, Linge A, Lohaus F, et al. Journal article